Lineage Cell Therapeutics Earnings Surprises image   This LCTX earnings surprises page last updated 3/21/2024
Lineage Cell Therapeutics Earnings Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 -0.04 -0.03 +0.01 (-25%)
Q2 2023 -0.04 -0.03 +0.01 (-25%)
Q1 2023 -0.04 -0.03 +0.01 (-25%)
Q4 2022 -0.04 -0.03 +0.01 (-25%)
Q3 2022 -0.03 -0.04 -0.01 (+33%)
Q1 2022 -0.03 -0.04 -0.01 (+33%)
Q4 2021 -0.05 -0.17 -0.12 (+240%)
Q2 2021 -0.04 -0.03 +0.01 (-25%)
Q1 2021 -0.04 -0.01 +0.03 (-75%)
Q4 2020 -0.05 0.01 +0.06 (-120%)
Q3 2020 -0.04 -0.05 -0.01 (+25%)
Q1 2020 -0.05 -0.06 -0.01 (+20%)
Q4 2019 -0.05 -0.03 +0.02 (-40%)
Q3 2019 -0.05 -0.11 -0.06 (+120%)
Q2 2019 -0.05 -0.20 -0.15 (+300%)
Q1 2019 -0.06 0.30 +0.36 (-600%)
Q4 2018 -0.07 -0.36 -0.29 (+414%)
Q3 2018 -0.07 0.53 +0.60 (-857%)
Q2 2018 -0.08 -0.03 +0.05 (-62%)
Q1 2018 -0.07 -0.50 -0.43 (+614%)
Q4 2017 -0.07 -0.58 -0.51 (+729%)
Q1 2017 -0.09 -0.08 +0.01 (-11%)
Q4 2016 -0.14 -0.05 +0.09 (-64%)
Q3 2016 -0.14 -0.09 +0.05 (-36%)
Q2 2016 -0.17 -0.11 +0.06 (-35%)
Q1 2016 -0.14 -0.19 -0.05 (+36%)
Lineage Cell Therapeutics Revenue Surprises Chart
PeriodExpectedActualSurprise
Q4 2023 1.31M 2.10M +790000 (+60%)
Q2 2023 2.20M 3.23M +1.02M (+47%)
Q1 2023 2.01M 2.39M +376000 (+19%)
Q4 2022 2.57M 1.90M -0.67M (-26%)
Q3 2022 3.90M 3.00M -0.90M (-23%)
Q1 2022 7.32M 5.24M -2.08M (-28%)
Q4 2021 840000 1.20M +360000 (-100%)
Q2 2021 480000 512000 +32000 (+7%)
Q1 2021 790000 391000 -0.40M (-51%)
Q4 2020 920000 355000 -0.56M (-61%)
Q3 2020 430000 571000 +141000 (+33%)
Q1 2020 710000 514000 -0.20M (-28%)
Q4 2019 1.03M 1.24M +211000 (+20%)
Q3 2019 810000 567000 -0.24M (-30%)
Q2 2019 990000 779000 -0.21M (-21%)
Q1 2019 910000 928000 +18000 (+2%)
Q4 2018 590000 758000 +168000 (+28%)
Q3 2018 680000 982000 +302000 (+44%)
Q2 2018 560000 2.55M +1.99M (-100%)
Q1 2018 710000 701000 -9000 (-1%)
Q4 2017 940000 999000 +59000 (+6%)
Q1 2017 500000 390000 -0.11M (-22%)
Q4 2016 1.00M 1.08M +83000 (+8%)
Q3 2016 1.23M 1.50M +269000 (+22%)
Q2 2016 1.70M 1.27M -0.43M (-25%)
Q1 2016 1.43M 2.07M +643000 (+45%)
Quotes delayed 20 minutes

Email EnvelopeFree LCTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Rockwell Medical (RMTI): 3/21/2024 6:00 AM
Fennec Pharmaceuticals (FENC): 3/21/2024 6:01 AM
X4 Pharmaceuticals (XFOR): 3/21/2024 6:05 AM
Shoe Carnival (SCVL): 3/21/2024 6:15 AM
Accenture (ACN): 3/21/2024 6:45 AM
Commercial Metals (CMC): 3/21/2024 6:45 AM
Titan Machinery (TITN): 3/21/2024 6:45 AM
Designer Brands (DBI): 3/21/2024 6:45 AM
Darden Restaurants (DRI): 3/21/2024 7:00 AM
FactSet Research Systems (FDS): 3/21/2024 7:00 AM

More from the Next Earnings Dates Calendar

Earnings History:

Nortech Systems (NSYS): 3/20/2024 After close
Enerpac Tool Group (EPAC): 3/20/2024 After close
Worthington Industries (WOR): 3/20/2024 After close
Sadot Group (SDOT): 3/20/2024 After close
Hall Of Fame Resort (HOFV): 3/20/2024 After close
Chewy (CHWY): 3/20/2024 After close
Guess (GES): 3/20/2024 After close
CuriosityStream (CURI): 3/20/2024 After close
Envela (ELA): 3/20/2024 After close
KB Home (KBH): 3/20/2024 After close

More from the Earnings History archive
On this page we presented the LCTX earnings surprises information for Lineage Cell Therapeutics, comparing the expected earnings versus the actual earnings quarter by quarter, with the resulting positive or negative percentage surprise. Any self directed investor doing their due diligence on LCTX (or any other given stock) can benefit from researching all of the Lineage Cell Therapeutics past earnings going backwards in time, including how often the company beat or missed the market's expectations. To help you with this Lineage Cell Therapeutics earnings surprise research, on this page we presented each quarter's resulting numbers for easy comparison. Studying these numbers can help an investor by providing important context with which to think about LCTX's next earnings report. In your continued research on Lineage Cell Therapeutics we hope you will be sure to check out the further links included for revenue and earnings history as well as next earnings dates for LCTX. Thanks for visiting, and the next time you need to research LCTX earnings surprises or those of another stock, we hope you'll think of our site as your go-to earnings surprises research resource of choice.

Recommended: MXCT shares outstanding history, Institutional Holders of LIOX, OLPX Average Annual Return.

 

Lineage Cell Therapeutics Earnings Surprises | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.